GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PharmaResearch Co 214450.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

236,000

+0.64%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

18 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 7Strong buy
  • 9Buy
  • 2Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 236,000Average target 630,823.64

Low
373,700
Average
630,823.64
Median
612,000
High
843,150

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029
Revenue₩685.76bn₩830.24bn₩988.87bn₩1.19trn
Revenue, highest₩707.38bn₩900.49bn₩1.05trn₩1.26trn
Revenue, lowest₩666.18bn₩730.86bn₩911.38bn₩1.10trn
Earnings per share18861.9722481.3927038.63—
Earnings per share, highest21009.5525754.3729166.44—
Earnings per share, lowest17318.3819976.5924284.40—
Analysts1315610

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast4043.923557.033686.323697.194303.193120.962571.012533.17
Reported4043.923733.322583.384234.134099.003287.002407.001860.00
Difference0.0%+5.0%-29.9%+14.5%-4.7%+5.3%-6.4%-26.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

9 / 10

Revenue growth 30.5% a year over 10 years. Return on equity 24.0%.

Model fair value

401,935.75

From earnings 401,935.75, from revenue 397,242.61.

Piotroski score

8 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.